search
Back to results

Transforming Hemodialysis-Related Vascular Access Education (THRiVE)

Primary Purpose

Chronic Kidney Disease, Hemodialysis Vascular Access

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Educational Materials
Motivational Interviewing
Usual Care
Patient Lists for Clinicians: System-Level Intervention
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Chronic Kidney Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age 18 years or older Nephrology visit for chronic kidney disease during the last 18 months Most recent eGFR less than or equal to 20 ml/min/1.73 m2 or 2-year Kidney Failure Risk Equation score greater than 40% Documentation in the medical record or confirmation from the treating nephrologist of a patient-nephrologist discussion about hemodialysis Exclusion Criteria: Planning for peritoneal dialysis, preemptive transplant, or conservative management of kidney failure Previous placement of an AV access Prior or scheduled appointment with surgeon for AV access evaluation or creation Cognitive dysfunction or severe visual impairment that prevents use of the education materials Does not speak either English or Spanish

Sites / Locations

  • University of North Carolina at Chapel Hill
  • University of Pennsylvania

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Other

Arm Label

Education

Education-Plus

Usual Care

Arm Description

Outcomes

Primary Outcome Measures

Surgery for Creation of Hemodialysis Arteriovenous Access (Effectiveness outcome)
The proportion of participants who have arteriovenous access creation surgery.

Secondary Outcome Measures

Scheduled Appointment with Surgeon for Vascular Access Evaluation (Effectiveness outcome)
The proportion of participants with a scheduled appointment with a surgeon for evaluation for vascular access creation.
Completed Appointment with Surgeon for Vascular Access Evaluation (Effectiveness outcome)
The proportion of participants with a completed appointment with a surgeon for evaluation for vascular access creation.
Imaging for Planning Arteriovenous Vascular Access Creation (Effectiveness outcome)
The proportion of participants with completed vascular imaging via ultrasound or angiography for planning arteriovenous vascular access creation surgery.
Usable Arteriovenous Vascular Access (Effectiveness outcome)
For participants who start hemodialysis, the proportion with a usable arteriovenous access at dialysis initiation.
Vascular Access Knowledge (Effectiveness outcome)
The change from baseline in vascular access knowledge as measured by the Patient Perceived Vascular Access Knowledge scale. The total score ranges from 0 to 10, with higher scores indicating a higher level of vascular access knowledge.
Decision Self-Efficacy (Effectiveness outcome)
The change from baseline in decision self-efficacy as measured by the Decision Self-Efficacy Scale. The total score ranges from 0 to 11, with higher scores indicating a higher level of self-efficacy when making decisions about hemodialysis vascular access.
Patient Activation Measure (Effectiveness outcome)
The change from baseline in patient activation as measured by the Patient Activation Measure. The total score ranges from 0 to 100, with higher scores indicating a higher level of engagement in self-management tasks.
Preparedness for Decision-Making (Effectiveness outcome)
A participant's level of preparedness for decision-making as measured by the Preparation for Decision-Making Scale. The total score ranges from 0-100, with higher scores indicating a higher perceived level of preparation for decision-making.
Characteristics of Eligible Patients - quantitative reach assessment (Implementation outcome)
An assessment of the demographic and socioeconomic characteristics of patients who are eligible for the trial.
Characteristics of Enrolled Participants - quantitative reach assessment (Implementation outcome)
An assessment of the demographic and socioeconomic characteristics of patients who enroll in the trial.
Characteristics of Participants who Complete the Trial - quantitative reach assessment (Implementation outcome)
An assessment of the demographic and socioeconomic characteristics of participants who complete the trial.
Characteristics of Participants who Withdraw from the Trial - quantitative reach assessment (Implementation outcome)
An assessment of the demographic and socioeconomic characteristics of participants who withdraw from the trial.
Declined Enrollment - quantitative reach assessment (Implementation outcome)
The reasons for declining enrollment as documented in screening logs and provided in aggregate for an enrolling center.
Reasons for Participation - qualitative reach assessment (Implementation outcome)
The reasons for participation and non-participation as identified through qualitative interviews
Reasons Nephrologists Opt-Out on Behalf of Patients - qualitative reach assessment (Implementation outcome)
The reasons that nephrologists opt out of having an eligible patient approached by the research team for possible enrollment as identified through qualitative interviews.
Acceptability Intervention Measure - quantitative acceptability assessment (Implementation outcome)
The acceptability of the intervention as measured by the Acceptability of Intervention Measure (AIM). The total score ranges from 1-5, with higher scores indicating a higher level of acceptability of the intervention.
Acceptability of Intervention Content, Delivery, and Accessibility - qualitative acceptability assessment (Implementation outcome)
The acceptability of the content, delivery, and accessibility of educational materials and motivational interviewing coaching as identified through qualitative interviews.
Chronic Kidney Disease Class Attendance - quantitative fidelity assessment (Implementation outcome)
The proportion of participants who attend a Chronic Kidney Disease education class provided by their nephrology clinic
Receipt of Educational Materials - quantitative fidelity assessment (Implementation outcome)
The proportion of participants with confirmed receipt of the "Getting Ready" brochure (only be assessed for the Education and Education-Plus groups)
Viewing of Video - quantitative fidelity assessment (Implementation outcome)
The proportion of participants with confirmed viewing of the "Getting Ready" video, which will only be assessed for the Education and Education-Plus groups.
Completed Motivational Interviewing Sessions - quantitative fidelity assessment (Implementation outcome)
The proportion of participants who completed the scheduled motivational interviewing sessions (only be assessed for the Education-Plus group)
Brochure Delivery Mode - quantitative barriers/facilitators assessment (Implementation outcome)
The selected mode for delivery of the "Getting Ready" brochure by center, clinic, and participant sociodemographic characteristics.
Video Delivery Mode - quantitative barriers/facilitators assessment (Implementation outcome)
The selected mode for viewing of the "Getting Ready" video by center, clinic, and participant sociodemographic characteristics.
Participant Contact Attempts for Motivational Interviewing - quantitative barriers/facilitators assessment (Implementation outcome)
The number and type (email, phone, text messaging) of attempted and confirmed participant contacts by the motivational interviewing coach.
Missed Motivational Interviewing Sessions - quantitative barriers/facilitators assessment (Implementation outcome)
The number of missed motivational interviewing sessions.
System-Level Barriers to Arteriovenous Access Creation From Clinical Staff Perspective - qualitative implementation/barriers assessment (Implementation outcome)
System-level barriers to arteriovenous vascular access creation and relevant system contextual factors as identified through qualitative interviews.
System-Level Barriers to Arteriovenous Access Creation From Participant Perspective - qualitative implementation/barriers assessment (Implementation outcome)
System-level barriers to arteriovenous vascular access creation and relevant system contextual factors as identified through qualitative interviews.

Full Information

First Posted
July 19, 2023
Last Updated
October 23, 2023
Sponsor
University of Pennsylvania
Collaborators
University of North Carolina, Chapel Hill, Johns Hopkins University
search

1. Study Identification

Unique Protocol Identification Number
NCT05997875
Brief Title
Transforming Hemodialysis-Related Vascular Access Education
Acronym
THRiVE
Official Title
Transforming Hemodialysis-Related Vascular Access Education (THRiVE)
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 2023 (Anticipated)
Primary Completion Date
September 2027 (Anticipated)
Study Completion Date
September 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pennsylvania
Collaborators
University of North Carolina, Chapel Hill, Johns Hopkins University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The focus of this study is on vascular access for hemodialysis. This is a randomized clinical trial testing 3 educational approaches to help patients with advanced chronic kidney disease prepare for placement of hemodialysis vascular access. Study participants will each be assigned to one of the 3 approaches: 1) "Education", in which participants will be given a video and brochure that provide information about the types of vascular access and what can be expected before and after the vascular access is placed, 2) "Education-Plus", in which participants will be given the video and brochure and will also have sessions by telehealth with a motivational interviewing coach to provide additional support around vascular access placement, and 3) "Usual Care", in which participants will have the usual education provided by their kidney doctor and clinic staff just as if they were not in the study. Participants in all 3 groups will be asked to complete questionnaires by telephone and may be invited to be interviewed about their experience with the study intervention at the end of the study. Study participation will last for about 12 months, with most of the study activities taking place during the first 3 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Disease, Hemodialysis Vascular Access

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
360 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Education
Arm Type
Experimental
Arm Title
Education-Plus
Arm Type
Experimental
Arm Title
Usual Care
Arm Type
Other
Intervention Type
Behavioral
Intervention Name(s)
Educational Materials
Intervention Description
Participants are provided with the "Getting Ready: Your Vascular Access Journey" video and brochure about hemodialysis vascular access. The video is available for viewing via smartphone or computer. Both the brochure and video were created with input from patients with chronic kidney disease.
Intervention Type
Behavioral
Intervention Name(s)
Motivational Interviewing
Intervention Description
Participants receive coaching with telehealth-based motivational interviewing designed to prepare participants to move forward with vascular access creation. Motivational interviewing will consist of a minimum of 3 and maximum of 8 telehealth sessions with a coach. The coach will use patient-centered communication skills to work though the stages of pre-contemplative, contemplative, preparation, action, and maintenance of an arteriovenous vascular access.
Intervention Type
Behavioral
Intervention Name(s)
Usual Care
Intervention Description
Participants receive the non-standardized vascular access counseling and referral to the chronic kidney disease education class that comprises the standard care provided by their nephrology clinic.
Intervention Type
Other
Intervention Name(s)
Patient Lists for Clinicians: System-Level Intervention
Intervention Description
Nephrologists and clinic staff receive monthly, provider-specific, lists of patients potentially appropriate for AV access planning based on eGFR thresholds and kidney failure risk. These criteria identify patients at risk for progression to dialysis and are congruent with evidence-based guidelines for optimal timing of AV access evaluation referral.
Primary Outcome Measure Information:
Title
Surgery for Creation of Hemodialysis Arteriovenous Access (Effectiveness outcome)
Description
The proportion of participants who have arteriovenous access creation surgery.
Time Frame
Within 12 months after randomization or before hemodialysis initiation, whichever comes first
Secondary Outcome Measure Information:
Title
Scheduled Appointment with Surgeon for Vascular Access Evaluation (Effectiveness outcome)
Description
The proportion of participants with a scheduled appointment with a surgeon for evaluation for vascular access creation.
Time Frame
Within 12 months after randomization or before hemodialysis initiation, whichever comes first
Title
Completed Appointment with Surgeon for Vascular Access Evaluation (Effectiveness outcome)
Description
The proportion of participants with a completed appointment with a surgeon for evaluation for vascular access creation.
Time Frame
Within 12 months after randomization or before hemodialysis initiation, whichever comes first
Title
Imaging for Planning Arteriovenous Vascular Access Creation (Effectiveness outcome)
Description
The proportion of participants with completed vascular imaging via ultrasound or angiography for planning arteriovenous vascular access creation surgery.
Time Frame
Within 12 months after randomization or before hemodialysis initiation, whichever comes first
Title
Usable Arteriovenous Vascular Access (Effectiveness outcome)
Description
For participants who start hemodialysis, the proportion with a usable arteriovenous access at dialysis initiation.
Time Frame
Up to 4 years after randomization (full duration of the trial)
Title
Vascular Access Knowledge (Effectiveness outcome)
Description
The change from baseline in vascular access knowledge as measured by the Patient Perceived Vascular Access Knowledge scale. The total score ranges from 0 to 10, with higher scores indicating a higher level of vascular access knowledge.
Time Frame
12 weeks after randomization
Title
Decision Self-Efficacy (Effectiveness outcome)
Description
The change from baseline in decision self-efficacy as measured by the Decision Self-Efficacy Scale. The total score ranges from 0 to 11, with higher scores indicating a higher level of self-efficacy when making decisions about hemodialysis vascular access.
Time Frame
12 weeks after randomization
Title
Patient Activation Measure (Effectiveness outcome)
Description
The change from baseline in patient activation as measured by the Patient Activation Measure. The total score ranges from 0 to 100, with higher scores indicating a higher level of engagement in self-management tasks.
Time Frame
12 weeks after randomization
Title
Preparedness for Decision-Making (Effectiveness outcome)
Description
A participant's level of preparedness for decision-making as measured by the Preparation for Decision-Making Scale. The total score ranges from 0-100, with higher scores indicating a higher perceived level of preparation for decision-making.
Time Frame
12 weeks after randomization
Title
Characteristics of Eligible Patients - quantitative reach assessment (Implementation outcome)
Description
An assessment of the demographic and socioeconomic characteristics of patients who are eligible for the trial.
Time Frame
Pre-Enrollment
Title
Characteristics of Enrolled Participants - quantitative reach assessment (Implementation outcome)
Description
An assessment of the demographic and socioeconomic characteristics of patients who enroll in the trial.
Time Frame
Baseline
Title
Characteristics of Participants who Complete the Trial - quantitative reach assessment (Implementation outcome)
Description
An assessment of the demographic and socioeconomic characteristics of participants who complete the trial.
Time Frame
12 months
Title
Characteristics of Participants who Withdraw from the Trial - quantitative reach assessment (Implementation outcome)
Description
An assessment of the demographic and socioeconomic characteristics of participants who withdraw from the trial.
Time Frame
From eligibility until 12 months
Title
Declined Enrollment - quantitative reach assessment (Implementation outcome)
Description
The reasons for declining enrollment as documented in screening logs and provided in aggregate for an enrolling center.
Time Frame
Pre-enrollment
Title
Reasons for Participation - qualitative reach assessment (Implementation outcome)
Description
The reasons for participation and non-participation as identified through qualitative interviews
Time Frame
12-16 weeks after randomization
Title
Reasons Nephrologists Opt-Out on Behalf of Patients - qualitative reach assessment (Implementation outcome)
Description
The reasons that nephrologists opt out of having an eligible patient approached by the research team for possible enrollment as identified through qualitative interviews.
Time Frame
Up to 4 years after trial initiation (full duration of the trial)
Title
Acceptability Intervention Measure - quantitative acceptability assessment (Implementation outcome)
Description
The acceptability of the intervention as measured by the Acceptability of Intervention Measure (AIM). The total score ranges from 1-5, with higher scores indicating a higher level of acceptability of the intervention.
Time Frame
12 -16 weeks after randomization
Title
Acceptability of Intervention Content, Delivery, and Accessibility - qualitative acceptability assessment (Implementation outcome)
Description
The acceptability of the content, delivery, and accessibility of educational materials and motivational interviewing coaching as identified through qualitative interviews.
Time Frame
12 to 16 weeks after randomization
Title
Chronic Kidney Disease Class Attendance - quantitative fidelity assessment (Implementation outcome)
Description
The proportion of participants who attend a Chronic Kidney Disease education class provided by their nephrology clinic
Time Frame
Within 12 months
Title
Receipt of Educational Materials - quantitative fidelity assessment (Implementation outcome)
Description
The proportion of participants with confirmed receipt of the "Getting Ready" brochure (only be assessed for the Education and Education-Plus groups)
Time Frame
Within 12 weeks after randomization
Title
Viewing of Video - quantitative fidelity assessment (Implementation outcome)
Description
The proportion of participants with confirmed viewing of the "Getting Ready" video, which will only be assessed for the Education and Education-Plus groups.
Time Frame
Within 12 weeks after randomization
Title
Completed Motivational Interviewing Sessions - quantitative fidelity assessment (Implementation outcome)
Description
The proportion of participants who completed the scheduled motivational interviewing sessions (only be assessed for the Education-Plus group)
Time Frame
Within 12 months after randomization
Title
Brochure Delivery Mode - quantitative barriers/facilitators assessment (Implementation outcome)
Description
The selected mode for delivery of the "Getting Ready" brochure by center, clinic, and participant sociodemographic characteristics.
Time Frame
Within 12 weeks after randomization
Title
Video Delivery Mode - quantitative barriers/facilitators assessment (Implementation outcome)
Description
The selected mode for viewing of the "Getting Ready" video by center, clinic, and participant sociodemographic characteristics.
Time Frame
Within 12 weeks after randomization
Title
Participant Contact Attempts for Motivational Interviewing - quantitative barriers/facilitators assessment (Implementation outcome)
Description
The number and type (email, phone, text messaging) of attempted and confirmed participant contacts by the motivational interviewing coach.
Time Frame
12 month period after randomization
Title
Missed Motivational Interviewing Sessions - quantitative barriers/facilitators assessment (Implementation outcome)
Description
The number of missed motivational interviewing sessions.
Time Frame
12 month period after randomization
Title
System-Level Barriers to Arteriovenous Access Creation From Clinical Staff Perspective - qualitative implementation/barriers assessment (Implementation outcome)
Description
System-level barriers to arteriovenous vascular access creation and relevant system contextual factors as identified through qualitative interviews.
Time Frame
Up to 4 years after trial initiation (full duration of the trial)
Title
System-Level Barriers to Arteriovenous Access Creation From Participant Perspective - qualitative implementation/barriers assessment (Implementation outcome)
Description
System-level barriers to arteriovenous vascular access creation and relevant system contextual factors as identified through qualitative interviews.
Time Frame
Within 12 months
Other Pre-specified Outcome Measures:
Title
Creation of Arteriovenous Vascular Access Without Subsequent Need for Hemodialysis
Description
The creation of an arteriovenous vascular access without a subsequent need for hemodialysis is a potential unintended consequence of interventions.
Time Frame
Up to 4 years after randomization (full duration of the trial)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18 years or older Nephrology visit for chronic kidney disease during the last 18 months Most recent eGFR less than or equal to 20 ml/min/1.73 m2 or 2-year Kidney Failure Risk Equation score greater than 40% Documentation in the medical record or confirmation from the treating nephrologist of a patient-nephrologist discussion about hemodialysis Exclusion Criteria: Planning for peritoneal dialysis, preemptive transplant, or conservative management of kidney failure Previous placement of an AV access Prior or scheduled appointment with surgeon for AV access evaluation or creation Cognitive dysfunction or severe visual impairment that prevents use of the education materials Does not speak either English or Spanish
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Leah Bernardo
Phone
+1 215-746-4755
Email
lleah@pennmedicine.upenn.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Clara Walling
Email
clara.walling@pennmedicine.upenn.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laura M. Dember, MD
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jennifer E. Flythe, MD, MPH
Organizational Affiliation
University of North Carolina, Chapel Hill
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Deidra Crews, MD, ScM
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of North Carolina at Chapel Hill
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27599
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer E. Flythe, MD, MPH
First Name & Middle Initial & Last Name & Degree
Jennifer E. Flythe, MD, MPH
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19106
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Clara Walling, BA
Phone
215-746-4181
Email
clara.walling@pennmedicine.upenn.edu
First Name & Middle Initial & Last Name & Degree
Laura M. Dember, MD

12. IPD Sharing Statement

Learn more about this trial

Transforming Hemodialysis-Related Vascular Access Education

We'll reach out to this number within 24 hrs